Cleveland, Ohio startup BioMotiv attracts $25 million investment from Japanese pharmaceutical giant

Story excerpt provided by The Plain Dealer.

Written by Robert L. Smith.

BioMotiv, a drug discovery company associated with University Hospitals, announced Thursday it has attracted a $25 million investment from Japan’s largest drug maker.

Takeda Pharmaceutical of Osaka will buy a minority stake in BioMotiv in exchange for exclusive access to its drugs that show promise treating cardio-metabolic diseases, like diabetes and heart disease, as well as diseases associated with immunology and inflammation.

Click here to read the complete article.

Originally published September 25, 2014.